Differences in variability of hypervariable region 1 of hepatitis C virus (HCV) between acute and chronic stages of HCV infection

In Silico Biology

Volumn 11, Issue 5, 2012, Pages 163-173

  Astrakhantseva, I V ^a   Campo, D S ^a   Araujo, A ^a   Teo, C G ^a   Khudyakov, Y ^a   Kamili, S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Acute; Chronic; HCV infection; Hypervariable region 1; Quasispecies

Indexed keywords

HVR1 PROTEIN, HEPATITIS C VIRUS; VIRUS PROTEIN;

ACUTE DISEASE; ARTICLE; CHEMICAL PHENOMENA; CHEMISTRY; CHRONIC DISEASE; GENETICS; HEPATITIS C VIRUS; HUMAN; POLYMERASE CHAIN REACTION; VIRUS GENOME;

ACUTE DISEASE; CHRONIC DISEASE; GENOME, VIRAL; HEPACIVIRUS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; POLYMERASE CHAIN REACTION; VIRAL PROTEINS;

EID: 84871960812     PISSN: 14343207     EISSN: None     Source Type: Journal    
DOI: 10.3233/ISB-2012-0451     Document Type: Article

References (56)

1. Alberti A, Chemello L, Benvegnu L, Natural history of hepatitis C, J Hepatol, v. 31 (1999), p. 17-24. (Pubitemid 30002686)
2. Alter M, Epidemiology of hepatitis C virus infection, World J Gastroenterol, 13 (2007), 2436-2441. (Pubitemid 46929498)
3. Alter M, Kruszon-Moran D, Nainan O, McQuillan G, Gao F, Moyer L, et al., The prevalence of hepatitis C virus infection in the United States, 1988 through 1994, N Engl J Med, 341 (1999), 6.
4. Araujo A, Astrakhantseva I, Fields H, Kamili S, Distinguishing acute from chronic hepatitis C virus (HCV) infection based on antibody reactivities to specific HCV structural and nonstructural proteins, J Clin Microbiol, 49 (2011), 54-57.
5. Bankwitz D, Steinmann E, Bitzegeio J, Ciesek S, Friesland M, Herrmann E, et al., Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes, J Virol, 84 (2010), 5751-5763.
6. Bowen D, Walker C, Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, 436 (2005), 946-952. (Pubitemid 41191670)
7. Brown RJ, Tarr AW, McClure CP, Juttla VS, Tagiuri N, Irving WL, et al., Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes., J Gen Virol, 88 (2007), 458-470.
8. Cade B, Richards J, User manual for BLOSSOM statistical software, Midcontinent Ecological Science Center US Geological Survey, (2001).
9. Cai L, Multi-response permutation procedure as an alternative to the analysis of variance: An SPSS implementation, Depart Psychol University N Carolina, (2004).
10. Callens N, Ciczora Y, Bartosch B, Vu-Dac N, Cosset FL, Pawlotsky JM, et al., Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein E2 contribute to virus entry, J Virol, 79 (2005), 15331-15341. (Pubitemid 43032315)
11. Campo D, Dimitrova Z, Khudyakov Y, Physicochemical correlation between amino acid sites in short sequences under selective pressure, In: Mandoiu I, Sunderraman R, Zelikovsky A, editors, Bioinformatics research and applications, Atlanta, GA, Springer; 2008, pp. 146-158.
12. Campo D, Dimitrova Z, Mitchell R, Lara J, Khudyakov Y, Coordinated evolution of the hepatitis C virus, PNAS, 105 (2008), 9685-9690. (Pubitemid 352031361)
13. Campo DS, Dimitrova Z, Yokosawa J, Hoang D, Perez NO, Ramachandran S, et al., Hepatitis C virus antigenic convergence, Sci Rep, 2 (2012), 267-277.
14. Choo Q, Kuo G, Weiner A, Overby L, Bradley D, Houghton M, Isolation of a cDNA clone derived from a bloodborne non-A, non-B viral hepatitis genome, Science, 244 (1989), 359-362. (Pubitemid 19117877)
15. Chung RT, Acute hepatitis C virus infection, Clinical Infection Disease, 41 Suppl 1 (2005), 14-17.
16. Coppola N, Pisapia R, Marrocco C, Martini S, Vatiero L, Messina V, et al., Anti-HCV IgG avidity index in acute hepatitis C, J Clin Virol, 40 (2007), 110-115. (Pubitemid 47419428)
17. Demsar J, Leban G, Zupan B, FreeViz-an intelligent multivariate visualization approach to explorative analysis of biomedical data, J Biomed Inform, 40 (2007), 661-671. (Pubitemid 350088616)
18. Eckels DD, Wang Y, Bian TH, Tabatabai N, Gill JC, Immunoboilogy of hepatitis C virus (HCV) infection: the role of CD4 T-cells in HCV infection., Immunol Rev, 174 (2000), 90-97. (Pubitemid 30201381)
19. Erickson AL,Kimura Y, Igarashi S, Eichelberger J,Houghton M, Sidney J, et al., The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes, Immunity, 15 (2001), 883-895. (Pubitemid 34075370)
20. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder J, et al., The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies, Science, 288 (2000), 339-344. (Pubitemid 30226196)
21. Forns X, Thimme R, Govindarajan S, Emerson S, Purcell R, Chisari F, et al., Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees, PNAS, 97 (2000), 13318-13323.
22. Herring B, Tsui R, Peddada L, Wide range of quasispecies diversity during primary hepatitis C virus infection, J Virol, 79 (2005), 4340-4346. (Pubitemid 40388371)
23. Hino K, Korenaga M, Orito E, Katoh Y, Yamaguchi Y, Ren F, et al., Constrained genomic and conformational variability of the hypervariable region 1 of hepatitis C virus in chronically infected patients, J Viral Hepat, 9 (2002), 194-201. (Pubitemid 36005517)
24. Hoffman PE, Grinstein GG, Marx K, Grosse I, Stanley E, DNA visual and analytic data mining, Proceedings of IEEE Visualization ISBN, Phoenix, AZ, 1997, pp 437-441.
25. Klimashevskaya S, Obriadina A, Ulanova T, Bochkova G, Burkov A, Araujo A, et al., Distinguishing acute from chronic and resolved hepatitis C virus (HCV) infections by measurement of anti-HCV immunoglobulin G avidity index, J Clin Microbiol, 45 (2007), 3400-3403. (Pubitemid 47585671)
26. Kosakovsky S, Frost S, Datamonkey: rapid detection of selective pressure on individual sites of codon alignments, Bioinformatics, 21 (2005), 2531-2533. (Pubitemid 40731616)
27. Kosakovsky S, Frost S, Not so different after all: A comparison of methods for detecting amino acid sites under selection, Mol Biol Evol, 22 (2005), 1208-1222. (Pubitemid 40577758)
28. Kosakovsky S, Frost S, Muse S, HyPhy: hypothesis testing using phylogenies, Bioinformatics, 21 (2005), 676-679. (Pubitemid 40424796)
29. Kurosaki M, Enomoto N, Marumo F, Sato C, Evolution and selection of hepatitis C virus variants in patients with chronic hepatitis C, Virology, 205 (1994), 161-169. (Pubitemid 24360602)
30. Lara J, Xia G, Purdy M, Khudyakov Y, Coevolution of the hepatitis C virus polyprotein sites 1 in patients on combined pegylated interferon and ribavirin therapy, J Virol, 85 (2011), 3649-3663.
31. Leban G, Bratko I, Petrovic U, Curk T, Zupan B, VizRank: finding informative data projections in functional genomics by machine learning, Bioinformatics, 21 (2005), 413-414. (Pubitemid 40246620)
32. Lechner F, Wong DK, Dunbar PR, Analysis of successful immune responses in person infected with hepatitis C virus, J Exp Med, 191 (2000), 1499-1512. (Pubitemid 30257347)
33. Liu L, Fisher BE, Dowd KA, Astemborski J, Cox AL, Ray SC, Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection, J Virol, 84 (2010), 5067-5077.
34. Maheshawari A, Ray S, Thuluvath PJ, Acute hepatitis C, Lancet, 372 (2008), 321-332. (Pubitemid 352020441)
35. Marcellin, Hepatitis C: the clinical spectrum of the disease, J Hepatol, 31 (1999), 9-17.
36. McAllister J, Casino C, Davidson F, Power J, Lawlor E, Yap P, et al., Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort, J Virol, 72 (1998), 4893-4905. (Pubitemid 28215667)
37. McCune B, Grace J, Analysis of ecological communities, Gleneden Beach, MjM Software Design; 2002.
38. Mielke P, Berry K, Permutation methods: A distance function approach. New York, Springer-Verlag; 2001.
39. Mondelli MU, Cerino A, Segagni L, Meola A, Cividini A, Silini E, et al., Hypervariable region 1 of hepatitis C virus: immunological decoy or biologically relevant domain? Antiviral Research, 52 (2001), 153-159. (Pubitemid 32973690)
40. Nainan OV, Khristova ML, Byun K, Xia G, Taylor PE, Stevens CE, et al., Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection, J Med Virol, 68 (2002), 319-327.
41. Nei M, Li W, Mathematical model for studying genetic variation in terms of restriction endonucleases, PNAS, 76 (1979), 5269-5273. (Pubitemid 10236121)
42. Pawlotsky J, Therapy of hepatitis C: from empiricism to eradication, Hepatology, 43 (2006), 207-220.
43. Penin F, Combet C, Germanidis G, Frainais P, Deleage G, Pawlotsky J, Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment, J Virol, 75 (2001), 5703-5710. (Pubitemid 32488166)
44. Ramachandran S, Campo D, Dimitrova Z, Xia G, Purdy M, Khudyakov Y, Temporal variations in the hepatitis C virus intra-host population during chronic infection, J Virol, 85 (2011), 6369-6380.
45. Ramachandran S, Xia G, Ganova-Raeva L, Nainan O, Khudyakov Y, End point limiting dilution real time PCR assay for evaluation of HCV quasispecies in serum, Journal of Virological Methods, 151 (2008), 217-224.
46. Rispeter K, Lu M, Lechner S, Zibert A, Roggendorf M, Cloning and characterization of a complete open reading frame of the hepatitis C virus genome in only two cDNA fragments, J Gen Virol, 78 (1997), 2751-2759. (Pubitemid 27480813)
47. Schneider S, Roessli D, Excoffier L, ARLEQUIN version 2000: Software for population genetic data analysis, Geneva, Genetics and Biometry Laboratory, University of Geneva; 2000, 120 p.
48. Sheridan I, Pybus O, Holmes E, Klenerman P, High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression, J Virol, 78 (2004), 3447-3454. (Pubitemid 38568286)
49. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH, Yoshikura H, Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses, J Virol, 68 (1994), 1494-1500. (Pubitemid 24065713)
50. Smith D, Evolution of the hypervariable region of hepatitis C virus, J Viral Hepat, 6 (1999), 41-46. (Pubitemid 29349788)
51. Thimme R, Oldach D, Chang KM, Determinants of viral clearance and persistence during acute hepatitis C virus infection, J Exp Med, 194 (2001), 1395-1406. (Pubitemid 33081515)
52. Thomson E, Smith J, Klenerman P, The natural history of early hepatitis C virus evolution; lessons from a global outbreak in human immunodeficiency virus-1-infected individuals, Journal of General Virology, 92 (2011), 2227-2236.
53. Van Doorn L, Capriles I, Maertens G, DeLeys R, Murray K, Kos T, et al., Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses, J Virol, 69 (1995), 773-778.
54. von Hahn T, Yoon J, Alter H, Rice C, Rehermann B, Balfe P, et al., Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo, Gastroenterology, 132 (2007), 667-678. (Pubitemid 46274668)
55. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, et al., Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections, PNAS, 89 (1992), 3468-3472.
56. Yang Z, Swanson W, Codon-substitution models to detect adaptive evolution that account for heterogeneous selective pressures among site classes, Mol Biol Evol, 19 (2002), 49-57. (Pubitemid 34008046)